{"university":{"openalex_id":"I107639228","name":"University of Notre Dame"},"topic":"17alpha-estradiol","total_matching":3,"offset":0,"next_offset":null,"records":[{"doi":"https://doi.org/10.1101/2020.04.02.021238","title":"Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis (ALS)","source_url":"https://doi.org/10.1101/2020.04.02.021238","source_name":"bioRxiv (Cold Spring Harbor Laboratory)","cited_by_count":4,"is_open_access":true,"openalex_work_id":"W3014148405","publication_date":"2020-04-03","publication_year":2020,"university_research_work_topics":[{"topic_slug":"17alpha-estradiol"}]},{"doi":"https://doi.org/10.1093/braincomms/fcaa154","title":"Altered skeletal muscle glucose–fatty acid flux in amyotrophic lateral sclerosis","source_url":"https://doi.org/10.1093/braincomms/fcaa154","source_name":"Brain Communications","cited_by_count":67,"is_open_access":true,"openalex_work_id":"W3088625330","publication_date":"2020-01-01","publication_year":2020,"university_research_work_topics":[{"topic_slug":"17alpha-estradiol"}]},{"doi":"https://doi.org/10.5281/zenodo.4570199","title":"Altered skeletal muscle glucose–fatty acid flux in amyotrophic lateral sclerosis","source_url":"https://doi.org/10.5281/zenodo.4570199","source_name":"Zenodo (CERN European Organization for Nuclear Research)","cited_by_count":2,"is_open_access":true,"openalex_work_id":"W4287661745","publication_date":"2020-09-24","publication_year":2020,"university_research_work_topics":[{"topic_slug":"17alpha-estradiol"}]}],"automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}